LOGO
LOGO

FDA Calendar - Ionis Pharmaceuticals, Inc.

Company Name Ionis Pharmaceuticals, Inc.
IONS
Drug Name Olezarsen (sNDA)
Event Name FDA desicion on Olezarsen for the treatment of severe hypertriglyceridemia
Event Date 06/30/2026
Outcome Date
Outcome pending
Drug Status Priority Review
Rival Drugs
Market Potential
Other Approvals Olezarsen is approved in the U.S. and the European Union as TRYNGOLZA® for adults with familial chylomicronemia syndrome (FCS)
News
Return to FDA Calendar
Editors Pick
waltdisney 06052026 lt

Disney Q2 Profit Down, Sees Earnings Growth In FY26, FY27; Plans At Least $8 Bln Buyback; Stock Up

May 06, 2026 07:32 ET
gamestop 04052026 lt

GameStop Offers To Buy EBay In $55.5 Bln Cash, Stock Deal; EBay Shares Gain

May 04, 2026 06:05 ET
colgate 01052026 lt

Colgate-Palmolive Q1 Profit Down, Backs FY26 Earnings, Sales Growth View; Stock Up

May 01, 2026 08:09 ET
humana 29042026 lt

Humana Cuts FY26 EPS View, Backs Adj. Earnings Forecast After Weak Q1 Profit; Stock Drops

April 29, 2026 06:37 ET
Copyright © 2026 RTTNews. All rights reserved. By using this site, you agree to the Terms of Service. About Us   |   Contact Us   |   Privacy   |   Sitemap